Prolonged thalidomide therapy for human immunodeficiency virus-associated recurrent severe esophageal and oral aphthous ulcers.
DeVincenzo
J P
JP
Division of Infectious Diseases, Crippled Children's Foundation Research Center, Memphis, TN, USA.
Burchet
S K
SK
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D018791:CD4 Lymphocyte Count; D002675:Child, Preschool; D004935:Esophageal Diseases / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009059:Mouth Diseases / Q000150:complications / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use*; D014456:Ulcer / Q000150:complications / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D013792:Thalidomide